Connection

Louis Luttrell to Animals

This is a "connection" page, showing publications Louis Luttrell has written about Animals.
Connection Strength

1.379
  1. Transcriptomic characterization of signaling pathways associated with osteoblastic differentiation of MC-3T3E1 cells. PLoS One. 2019; 14(1):e0204197.
    View in: PubMed
    Score: 0.048
  2. The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling. Pharmacol Rev. 2017 07; 69(3):256-297.
    View in: PubMed
    Score: 0.043
  3. Translating in vitro ligand bias into in vivo efficacy. Cell Signal. 2018 01; 41:46-55.
    View in: PubMed
    Score: 0.042
  4. The conformational signature of ?-arrestin2 predicts its trafficking and signalling functions. Nature. 2016 Mar 31; 531(7596):665-8.
    View in: PubMed
    Score: 0.039
  5. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism. Mol Pharmacol. 2015 Sep; 88(3):579-88.
    View in: PubMed
    Score: 0.037
  6. Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentation. Methods. 2016 Jan 01; 92:51-63.
    View in: PubMed
    Score: 0.037
  7. Delineation of a conserved arrestin-biased signaling repertoire in vivo. Mol Pharmacol. 2015 Apr; 87(4):706-17.
    View in: PubMed
    Score: 0.036
  8. Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis. J Biol Chem. 2014 Sep 19; 289(38):26155-26166.
    View in: PubMed
    Score: 0.035
  9. Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery. Mol Endocrinol. 2014 Mar; 28(3):281-94.
    View in: PubMed
    Score: 0.034
  10. Emergent biological properties of arrestin pathway-selective biased agonism. J Recept Signal Transduct Res. 2013 Jun; 33(3):153-61.
    View in: PubMed
    Score: 0.032
  11. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity. Methods Enzymol. 2013; 522:229-62.
    View in: PubMed
    Score: 0.031
  12. Arrestin pathways as drug targets. Prog Mol Biol Transl Sci. 2013; 118:469-97.
    View in: PubMed
    Score: 0.031
  13. 'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass? Br J Pharmacol. 2011 Sep; 164(1):59-67.
    View in: PubMed
    Score: 0.029
  14. Refining efficacy: allosterism and bias in G protein-coupled receptor signaling. Methods Mol Biol. 2011; 756:3-35.
    View in: PubMed
    Score: 0.027
  15. Refining efficacy: exploiting functional selectivity for drug discovery. Adv Pharmacol. 2011; 62:79-107.
    View in: PubMed
    Score: 0.027
  16. A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med. 2009 Oct 07; 1(1):1ra1.
    View in: PubMed
    Score: 0.025
  17. Diversity in arrestin function. Cell Mol Life Sci. 2009 Sep; 66(18):2953-73.
    View in: PubMed
    Score: 0.025
  18. Insulin-like growth factor-2/mannose-6 phosphate receptors. Vitam Horm. 2009; 80:667-97.
    View in: PubMed
    Score: 0.024
  19. The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry. 2008 Nov 04; 47(44):11682-92.
    View in: PubMed
    Score: 0.023
  20. Heptahelical terpsichory. Who calls the tune? J Recept Signal Transduct Res. 2008; 28(1-2):39-58.
    View in: PubMed
    Score: 0.022
  21. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription. J Biol Chem. 2008 Jan 25; 283(4):2088-97.
    View in: PubMed
    Score: 0.022
  22. G protein-coupled receptor signaling complexity in neuronal tissue: implications for novel therapeutics. Curr Alzheimer Res. 2007 Feb; 4(1):3-19.
    View in: PubMed
    Score: 0.021
  23. Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. J Biol Chem. 2006 Oct 20; 281(42):31399-407.
    View in: PubMed
    Score: 0.020
  24. Signal switching, crosstalk, and arrestin scaffolds: novel G protein-coupled receptor signaling in cardiovascular disease. Hypertension. 2006 Aug; 48(2):173-9.
    View in: PubMed
    Score: 0.020
  25. Transmembrane signaling by G protein-coupled receptors. Methods Mol Biol. 2006; 332:3-49.
    View in: PubMed
    Score: 0.019
  26. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts. J Biol Chem. 2005 Sep 16; 280(37):32157-67.
    View in: PubMed
    Score: 0.019
  27. The origins of diversity and specificity in g protein-coupled receptor signaling. J Pharmacol Exp Ther. 2005 Aug; 314(2):485-94.
    View in: PubMed
    Score: 0.018
  28. Composition and function of g protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity. J Mol Neurosci. 2005; 26(2-3):253-64.
    View in: PubMed
    Score: 0.018
  29. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene. 2004 Oct 18; 23(48):7969-78.
    View in: PubMed
    Score: 0.018
  30. Ectodomain shedding-dependent transactivation of epidermal growth factor receptors in response to insulin-like growth factor type I. Mol Endocrinol. 2004 Nov; 18(11):2727-39.
    View in: PubMed
    Score: 0.017
  31. Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts. Mol Endocrinol. 2003 Aug; 17(8):1607-21.
    View in: PubMed
    Score: 0.016
  32. 'Location, location, location': activation and targeting of MAP kinases by G protein-coupled receptors. J Mol Endocrinol. 2003 Apr; 30(2):117-26.
    View in: PubMed
    Score: 0.016
  33. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem. 2003 Feb 21; 278(8):6258-67.
    View in: PubMed
    Score: 0.016
  34. Big G, little G: G proteins and actin cytoskeletal reorganization. Mol Cell. 2002 Jun; 9(6):1152-4.
    View in: PubMed
    Score: 0.015
  35. Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminus. J Biol Chem. 2002 Aug 09; 277(32):28631-40.
    View in: PubMed
    Score: 0.015
  36. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci. 2002 Feb 01; 115(Pt 3):455-65.
    View in: PubMed
    Score: 0.015
  37. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem. 2002 Mar 15; 277(11):9429-36.
    View in: PubMed
    Score: 0.015
  38. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A. 2001 Feb 27; 98(5):2449-54.
    View in: PubMed
    Score: 0.014
  39. Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem. 2000 Jul 21; 275(29):22583-9.
    View in: PubMed
    Score: 0.013
  40. ?-Arrestin2 is a critical component of the GPCR-eNOS signalosome. Proc Natl Acad Sci U S A. 2020 05 26; 117(21):11483-11492.
    View in: PubMed
    Score: 0.013
  41. The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem. 2000 Mar 31; 275(13):9572-80.
    View in: PubMed
    Score: 0.013
  42. Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J Biol Chem. 1999 May 14; 274(20):13978-84.
    View in: PubMed
    Score: 0.012
  43. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol. 1999 Apr; 11(2):177-83.
    View in: PubMed
    Score: 0.012
  44. GIT2-A keystone in ageing and age-related disease. Ageing Res Rev. 2018 May; 43:46-63.
    View in: PubMed
    Score: 0.011
  45. Regulation of mitogen-activated protein kinase pathways by catecholamine receptors. Adv Pharmacol. 1998; 42:466-70.
    View in: PubMed
    Score: 0.011
  46. G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol Chem. 1997 Dec 12; 272(50):31648-56.
    View in: PubMed
    Score: 0.011
  47. Regulator of G protein signaling 2 is a key regulator of pancreatic ?-cell mass and function. Cell Death Dis. 2017 05 25; 8(5):e2821.
    View in: PubMed
    Score: 0.011
  48. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J Biol Chem. 1997 Feb 14; 272(7):4637-44.
    View in: PubMed
    Score: 0.010
  49. S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization. J Lipid Res. 2017 02; 58(2):325-338.
    View in: PubMed
    Score: 0.010
  50. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem. 1996 Aug 09; 271(32):19443-50.
    View in: PubMed
    Score: 0.010
  51. Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis. Int J Biochem Cell Biol. 2016 08; 77(Pt B):240-50.
    View in: PubMed
    Score: 0.010
  52. G beta gamma subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase insulin-like growth factor 1 receptor. J Biol Chem. 1995 Jul 14; 270(28):16495-8.
    View in: PubMed
    Score: 0.009
  53. Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics. Methods. 2016 Jan 01; 92:36-50.
    View in: PubMed
    Score: 0.009
  54. Effect of cellular expression of pleckstrin homology domains on Gi-coupled receptor signaling. J Biol Chem. 1995 Jun 02; 270(22):12984-9.
    View in: PubMed
    Score: 0.009
  55. Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel. Mol Endocrinol. 2015 Jun; 29(6):896-908.
    View in: PubMed
    Score: 0.009
  56. Novel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator. J Biol Regul Homeost Agents. 2014 Oct-Dec; 28(4):587-603.
    View in: PubMed
    Score: 0.009
  57. Epidermal growth factor-induced proliferation of collecting duct cells from Oak Ridge polycystic kidney mice involves activation of Na+/H+ exchanger. Am J Physiol Cell Physiol. 2014 Sep 15; 307(6):C554-60.
    View in: PubMed
    Score: 0.009
  58. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. J Biol Chem. 2013 Jun 28; 288(26):18872-84.
    View in: PubMed
    Score: 0.008
  59. Textrous!: extracting semantic textual meaning from gene sets. PLoS One. 2013; 8(4):e62665.
    View in: PubMed
    Score: 0.008
  60. Angiotensin II activates NF-?B through AT1A receptor recruitment of ?-arrestin in cultured rat vascular smooth muscle cells. Am J Physiol Cell Physiol. 2013 Jun 15; 304(12):C1176-86.
    View in: PubMed
    Score: 0.008
  61. ?-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo. Mol Endocrinol. 2013 Feb; 27(2):296-314.
    View in: PubMed
    Score: 0.008
  62. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. Mol Endocrinol. 2012 May; 26(5):833-45.
    View in: PubMed
    Score: 0.007
  63. Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation. Mol Immunol. 2011 Oct; 49(1-2):64-74.
    View in: PubMed
    Score: 0.007
  64. A pertussis toxin-sensitive G-protein mediates some aspects of insulin action in BC3H-1 murine myocytes. J Biol Chem. 1990 Oct 05; 265(28):16873-9.
    View in: PubMed
    Score: 0.007
  65. Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors. J Biol Chem. 2010 Nov 05; 285(45):35206-15.
    View in: PubMed
    Score: 0.007
  66. Novel mechanisms in the regulation of G protein-coupled receptor trafficking to the plasma membrane. J Biol Chem. 2010 Oct 29; 285(44):33816-25.
    View in: PubMed
    Score: 0.007
  67. Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangement. J Pharmacol Exp Ther. 2010 Sep 01; 334(3):775-83.
    View in: PubMed
    Score: 0.007
  68. HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate. J Lipid Res. 2010 Sep; 51(9):2619-28.
    View in: PubMed
    Score: 0.007
  69. Beta-arrestin 2 negatively regulates sepsis-induced inflammation. Immunology. 2010 Jul; 130(3):344-51.
    View in: PubMed
    Score: 0.007
  70. Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders. J Pharmacol Exp Ther. 2009 Nov; 331(2):340-8.
    View in: PubMed
    Score: 0.006
  71. Angiotensin II-induced cyclooxygenase 2 expression in rat aorta vascular smooth muscle cells does not require heterotrimeric G protein activation. J Pharmacol Exp Ther. 2009 Jul; 330(1):118-24.
    View in: PubMed
    Score: 0.006
  72. Insulin and phorbol ester induce distinct phosphorylations of pp60c-src in the BC3H-1 murine myocyte cell line. Oncogene. 1989 Mar; 4(3):317-24.
    View in: PubMed
    Score: 0.006
  73. c-Src-mediated phosphorylation of AP-2 reveals a general mechanism for receptors internalizing through the clathrin pathway. Cell Signal. 2009 Jan; 21(1):103-10.
    View in: PubMed
    Score: 0.006
  74. Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J Biol Chem. 2007 Oct 05; 282(40):29549-62.
    View in: PubMed
    Score: 0.005
  75. Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. Mol Immunol. 2007 May; 44(12):3092-9.
    View in: PubMed
    Score: 0.005
  76. Hexose-independent activation of glycogen synthase and pyruvate dehydrogenase by insulin is dissociated in the mouse BC3H-1 cell line. Mol Pharmacol. 1986 Dec; 30(6):624-30.
    View in: PubMed
    Score: 0.005
  77. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. J Biol Chem. 2006 Jul 28; 281(30):21004-21012.
    View in: PubMed
    Score: 0.005
  78. Arrestin-mediated ERK activation by gonadotropin-releasing hormone receptors: receptor-specific activation mechanisms and compartmentalization. J Biol Chem. 2006 Feb 03; 281(5):2701-10.
    View in: PubMed
    Score: 0.005
  79. Beta-arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitization. Mol Endocrinol. 2005 Apr; 19(4):1078-87.
    View in: PubMed
    Score: 0.005
  80. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation. 2003 Sep 30; 108(13):1611-8.
    View in: PubMed
    Score: 0.004
  81. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci U S A. 2003 Sep 16; 100(19):10782-7.
    View in: PubMed
    Score: 0.004
  82. Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1 adrenergic receptor endocytosis through different pathways. J Biol Chem. 2003 Sep 12; 278(37):35403-11.
    View in: PubMed
    Score: 0.004
  83. Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor. J Biol Chem. 2002 Jul 19; 277(29):26642-51.
    View in: PubMed
    Score: 0.004
  84. beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem. 2001 Nov 23; 276(47):43663-7.
    View in: PubMed
    Score: 0.004
  85. G protein-coupled receptors desensitize and down-regulate epidermal growth factor receptors in renal mesangial cells. J Biol Chem. 2001 Jul 20; 276(29):27335-44.
    View in: PubMed
    Score: 0.004
  86. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J Biol Chem. 2001 Jun 22; 276(25):23155-60.
    View in: PubMed
    Score: 0.003
  87. Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J Biol Chem. 2000 Dec 08; 275(49):38131-4.
    View in: PubMed
    Score: 0.003
  88. Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity. Mol Cell Biol. 2000 Nov; 20(22):8352-63.
    View in: PubMed
    Score: 0.003
  89. Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors. Proc Natl Acad Sci U S A. 2000 Feb 15; 97(4):1489-94.
    View in: PubMed
    Score: 0.003
  90. The beta3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism. J Biol Chem. 1999 Apr 23; 274(17):12017-22.
    View in: PubMed
    Score: 0.003
  91. Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J Biol Chem. 1999 Feb 19; 274(8):4749-53.
    View in: PubMed
    Score: 0.003
  92. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 1999 Jan 29; 283(5402):655-61.
    View in: PubMed
    Score: 0.003
  93. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998 Apr 24; 280(5363):574-7.
    View in: PubMed
    Score: 0.003
  94. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem. 1997 Aug 01; 272(31):19125-32.
    View in: PubMed
    Score: 0.003
  95. G-protein-coupled receptors and their regulation: activation of the MAP kinase signaling pathway by G-protein-coupled receptors. Adv Second Messenger Phosphoprotein Res. 1997; 31:263-77.
    View in: PubMed
    Score: 0.003
  96. Mitogenic signaling via G protein-coupled receptors. Endocr Rev. 1996 Dec; 17(6):698-714.
    View in: PubMed
    Score: 0.003
  97. Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway. J Biol Chem. 1996 May 24; 271(21):12133-6.
    View in: PubMed
    Score: 0.002
  98. G(o)-protein alpha-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism. J Biol Chem. 1996 Jan 19; 271(3):1266-9.
    View in: PubMed
    Score: 0.002
  99. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J Biol Chem. 1995 Jul 21; 270(29):17148-53.
    View in: PubMed
    Score: 0.002
  100. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J Biol Chem. 1994 Jun 03; 269(22):15776-85.
    View in: PubMed
    Score: 0.002
  101. Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase. Proc Natl Acad Sci U S A. 1994 Apr 26; 91(9):3637-41.
    View in: PubMed
    Score: 0.002
  102. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling. J Biol Chem. 1994 Feb 25; 269(8):6193-7.
    View in: PubMed
    Score: 0.002
  103. Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators. Science. 1988 Apr 22; 240(4851):509-11.
    View in: PubMed
    Score: 0.001
  104. Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src. Mol Cell Biol. 1988 Jan; 8(1):497-501.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.